Showing 2591-2600 of 10620 results for "".
Tinnitus: The Everyday Toll on Our Patients
https://reachmd.com/programs/clinicians-roundtable/tinnitus-the-everyday-toll-on-our-patients/3087/A neurological condition that can be highly distressing, tinnitus affects as much as fifteen percent of our population, according to some surveys. How should medical professionals counsel their patients on this condition? Are we moving closer to understanding the basic triggers of tinnitus? Dr. RichLong-Forgotten Head Injuries as a Factor in Social Issues.
https://reachmd.com/programs/clinicians-roundtable/long-forgotten-head-injuries-as-a-factor-in-social-issues/2956/Substance abuse, homelessness, criminal behavior. Highlighting the surprising link between head injuries and these social ills with your host, Dr. Gary Kohn, is Dr. Wayne Gordon, the Jack Nash Professor of Rehabilitation Medicine and Associate Director of the Department of Rehabilitation Medicine atMedical Education and the Health Reform Debate
https://reachmd.com/programs/clinicians-roundtable/medical-education-and-the-health-reform-debate/2942/Dissecting the various agents for healthcare reform in the United States, one key area of participation must come from those who teach and train our medical professionals of tomorrow. How can academic medicine take a leading role in the healthcare reform debate? Dr. Darrell Kirch, president and CEOConflicts of Interest in Universal Health Care
https://reachmd.com/programs/clinicians-roundtable/conflicts-of-interest-in-universal-health-care/2892/As Massachusetts moves to authorize a mandate on individual health insurance, are these efforts hamstrung by state-level conflicts of interest? Will similar conflicts arise on the national level? Merrill Goozner, director of the Integrity in Science Project at the Center for Science in the Public InHow Do You Talk With Someone Who is Dying?
https://reachmd.com/programs/clinicians-roundtable/how-do-you-talk-with-someone-who-is-dying/2813/During this segment hear the coauthors of The End-of-Life Handbook, Dr. David Feldman and Dr. Andrew Lasher, offer their best advice for handling challenging issues surrounding the end of life.Noninvasive Imaging for the Vulnerable Patient
https://reachmd.com/programs/clinicians-roundtable/noninvasive-imaging-for-the-vulnerable-patient/2783/In this segment, Dr. Larry Kaskel welcomes our guest Dr. Matt Budoff Associate Professor of Medicine UCLA School of Medicine. They discuss the developments in noninvasive imaging and how these modalities are used in identifying patients with high levels of calcified plaque and high probability of bEndothelium Regulation and Dysfunction
https://reachmd.com/programs/clinicians-roundtable/endothelium-regulation-and-dysfunction/2748/What is the endothelium and how does it regulate itself in wellness and in illness? What are the consequences of endothelial dysfunction and how we can measure it? Join Host, Dr. Larry Kaskel talking with our guest Dr. Amir Lerman to answer these questions and more.Innovative Atherosclerosis Treatments
https://reachmd.com/programs/clinicians-roundtable/innovative-atherosclerosis-treatments/2747/The Society for Heart Attack Prevention and Eradication, SHAPE is focused on several primary interventions to eliminate heart attacks. Join Dr. Larry Kaskel interviewing Dr. Morteza Naghavi and Dr. P.K. Shah to learn about several of SHAPES' top priorities including the polypill and the vaccinationEthical Issues in a Pandemic: Standard of Care
https://reachmd.com/programs/focus-on-disaster-medicine-and-preparedness/ethical-issues-in-a-pandemic-standard-of-care/2744/Dr. Nancy Berlinger speaks about how an epidemic can alter the standard of care and the perception of the public to these changes. If leadership is not prepared to have the larger community embrace these alterations in ethics, physicians will feel the threat of litigation. Dr. Maurice Pickard hosts.The History of Research Into Vaccines for Shingles
https://reachmd.com/programs/clinicians-roundtable/the-history-of-research-into-vaccines-for-shingles/2725/Decades of research have gone into the isolation and refinement of a vaccine for adult shingles, approved in 2006 by the FDA and in use today. Do we now fully understand the mechanism which activates the latent varicella-zoster virus, leading to adult shingles? How did initial isolation, going back